Kevin focuses on antitrust merger review, including pre-transaction counseling, merger investigations and merger litigations. He previously served as head of the FTC’s Mergers IV Division, where he led investigations in proposed transactions in key industries, including retail, consumer products, distribution, hospitals and other healthcare providers.

Kevin brings over 25 years of antitrust experience from both the FTC and private practice. He has extensive experience reviewing, investigating and litigating merger transactions. As head of the Mergers IV Division, Kevin led teams in several prominent FTC merger challenges and spearheaded FTC review of numerous high-profile transactions. 

Kevin also served as Counsel to the Director in the Bureau of Competition Front Office where he assisted in overseeing the Mergers III Division (oil and gas industries, including pipelines, terminals and retailing) and Anticompetitive Practices Division (civil non-merger conduct). 

Bar Admissions

Education
JD, Tulane University Law School, cum laude, 1996

BA, Swarthmore College, 1989

• Health Mergers May Face Antitrust Hurdles Amid Pandemic, Law360
• FTC Lawsuit Debuts New Enforcement Agenda Targeting Private Equity “Roll-Up” Acquisitions Against Texas Anesthesia Provider and PE Sponsor Alleging Multiple Antitrust Violations, American Health Law Association
• FTC Studying Supply Chain Disruption, With Orders to Nine, Retail Industry 2021 Year in Review
• Antitrust trends and considerations for physician mergers, Medical Economics
• Overview of Private Merger Challenges Filed Since 2000
• FTC Antitrust Enforcement Post-AMG Capital Management, Some Assembly Required, (AHLA) American Health Law Association
• FTC and Rhode Island AG Successfully Blocked Merger Between Rhode Island’s Two Largest Health Systems and Signaled Potential New Direction for Merger Enforcement, American Health Law Association
• Clarifying Bundle Markets and Distinguishing Them from Cluster Markets, The Antitrust Source, ABA Journals
• Recent Private Merger Challenges: Anomaly or Harbinger?, Antitrust
• Addendum to article in Antitrust Magazine “Private Merger Challenges: Anomaly or Harbinger?”, Antitrust Magazine
• New, higher HSR thresholds and filing fees for 2024, Westlaw Today
• Looking Into the Merger Review Crystal Ball: New Trends That Will Shape Future Enforcement, Retail Industry 2022 Year in Review
• FTC Lawsuit Debuts New Enforcement Agenda Targeting Private Equity “Roll-Up” Acquisitions Against Texas Anesthesia Provider and PE Sponsor Alleging Multiple Antitrust Violations, Health Law Weekly
• Three Key Things in Health Care
• Three Key Things in Health Care
• Three Key Things in Health Care
• M&A Quarterly Reporter – 2021 Q3
• A Tale Of Two Cases: Lessons In No-Poach Litigation, Law360